Repare Therapeutics logo

Repare Therapeutics Share Price Today

(NASDAQ: RPTX)

Repare Therapeutics share price is $1.21 & ₹105.23 as on 6 Mar 2025, 2.30 'hrs' IST

$1.21

0.04

(3.42%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Repare Therapeutics share price in Dollar and Rupees. Guide to invest in Repare Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Repare Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Repare Therapeutics share price movements

  • Today's Low: $1.16
    Today's High: $1.23

    Day's Volatility :5.31%

  • 52 Weeks Low: $1.06
    52 Weeks High: $6.91

    52 Weeks Volatility :84.66%

Repare Therapeutics (RPTX) Returns

PeriodRepare Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-60.61%
2.1%
0.0%
6 Months
-57.45%
-4.1%
0.0%
1 Year
-80.63%
2.2%
0.0%
3 Years
-91.85%
11.8%
-11.6%

Repare Therapeutics (RPTX) Key Statistics

in dollars & INR

Previous Close
$1.17
Open
$1.19
Today's High
$1.225
Today's Low
$1.16
Market Capitalization
$49.3M
Today's Volume
$35.8K
52 Week High
$6.91
52 Week Low
$1.06
Revenue TTM
$66.5M
EBITDA
$-90.2M
Earnings Per Share (EPS)
$-1.99
Profit Margin
-126.34%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-41.17%

How to invest in Repare Therapeutics Stock (RPTX) from India?

It is very easy for Indian residents to invest directly in Repare Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Repare Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Repare Therapeutics or RPTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Repare Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Repare Therapeutics shares which would translate to 0.719 fractional shares of Repare Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Repare Therapeutics, in just a few clicks!

Returns in Repare Therapeutics (RPTX) for Indian investors in Rupees

The Repare Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Repare Therapeutics investment value today

Current value as on today

₹24,996

Returns

₹75,004

(-75%)

Returns from Repare Therapeutics Stock

₹79,967 (-79.97%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Repare Therapeutics (RPTX)

-86%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Repare Therapeutics Stock from India on INDmoney has decreased by -86% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Repare Therapeutics

  • Bvf Inc

    24.31%

  • Blue Owl Capital Holdings LP

    8.10%

  • Orbimed Advisors, LLC

    7.82%

  • Versant Venture Management LLC

    6.23%

  • ARK Investment Management LLC

    4.70%

  • Redmile Group, LLC

    4.51%

Analyst Recommendation on Repare Therapeutics

Buy

    84%Buy

    15%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Repare Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Repare Therapeutics Stock (RPTX)

What analysts predicted

Upside of 437.19%

Target:

$6.50

Current:

$1.21

Insights on Repare Therapeutics Stock (Ticker Symbol: RPTX)

  • Price Movement

    In the last 3 months, RPTX stock has moved down by -60.6%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 52.40M → 1.07M (in $), with an average decrease of 98.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -34.77M → -34.40M (in $), with an average increase of 1.1% per quarter
  • RPTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 144.5%
  • RPTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 139.6%
  • Price to Sales

    ForRPTX every $1 of sales, investors are willing to pay $0.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Repare Therapeutics Technicals Summary

Sell

Neutral

Buy

Repare Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Repare Therapeutics (RPTX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Repare Therapeutics Inc logo
-4.1%
-57.45%
-80.63%
-91.85%
-96.2%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Repare Therapeutics Inc logo
NA
NA
NA
-2.51
-0.41
-0.23
NA
4.12
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Repare Therapeutics Inc logo
Buy
$49.3M
-96.2%
NA
-126.34%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Repare Therapeutics

Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synthetic lethality approach in Canada and the United States. It uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform, to discover, validate, and build a pipeline of SL-based therapeutics that focuses on genomic instability, including DNA damage repair. The company's lead product candidate is Camonsertib (RP-3500), an oral small molecule inhibitor under Phase ½ development for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing Lunresertib (RP-6306), a PKMYT1 Inhibitor, which is under Phase I/Ib clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; RP-1664, an oral PLK4 inhibitor, under Phase 1 clinical trial designed to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, a polymerase theta adenosinetriphosphatase (ATPase) inhibitor, a SL target associated with BRCA mutations and other genomic alterations. The company has license and collaboration agreement with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche Ltd; Bristol-Myers Squibb Company; New York University; Foundation Medicine, Inc. for the provision of prospective genomic profiling of lunresertib alone or in combinations in genomically-defined patient populations; cooperative research and development agreement with US National Cancer Institute to advance the development of Camonsertib; and Ono Pharmaceutical Co., as well as a clinical study and collaboration agreement with Debiopharm to explore the synthetic lethal combination of PKMYT1 and WEE1 inhibition in cancer. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.
Organization
Repare Therapeutics
Employees
179
CEO
Mr. Lloyd Mitchell Segal
Industry
Health Technology

Management People of Repare Therapeutics

NameTitle
Mr. Lloyd Mitchell Segal
President, CEO & Director
Mr. Steve Forte CPA
Executive VP & CFO
Dr. Maria Koehler M.D., Ph.D.
Executive VP & Chief Medical Officer
Dr. Daniel Durocher Ph.D.
Co-Founder
Dr. Frank Sicheri Ph.D.
Co-Founder
Dr. Agnel Sfeir Ph.D.
Co-Founder
Dr. Michael Zinda Ph.D.
Executive VP & Chief Scientific Officer
Ms. Robin Thai Garner Kalley
VP & Head of Investor Relations
Mr. Daniel Belanger
Executive Vice President of Human Resource
Mr. Cameron Black Ph.D.
Executive Vice President of Discovery

Important FAQs about investing in RPTX Stock from India :

What is Repare Therapeutics share price today?

Repare Therapeutics share price today stands at $1.21, Open: $1.19 ; Previous Close: $1.17 ; High: $1.23 ; Low: $1.16 ; 52 Week High: $6.91 ; 52 Week Low: $1.06.

The stock opens at $1.19, after a previous close of $1.17. The stock reached a daily high of $1.23 and a low of $1.16, with a 52-week high of $6.91 and a 52-week low of $1.06.

Can Indians buy Repare Therapeutics shares?

Yes, Indians can invest in the Repare Therapeutics (RPTX) from India.

With INDmoney, you can buy Repare Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Repare Therapeutics at zero transaction cost.

How can I buy Repare Therapeutics shares from India?

It is very easy to buy Repare Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Repare Therapeutics (RPTX) be purchased?

Yes, you can buy fractional shares of Repare Therapeutics with INDmoney app.

What are the documents required to start investing in Repare Therapeutics stocks?

To start investing in Repare Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Repare Therapeutics Stock (RPTX)?

Today’s highest price of Repare Therapeutics (RPTX) is $1.23.

Today’s lowest price of Repare Therapeutics (RPTX) is $1.16.

What is today's market capitalisation of Repare Therapeutics?

Today's market capitalisation of Repare Therapeutics RPTX is 49.3M

What is the 52 Week High and Low Range of Repare Therapeutics Stock (RPTX)?

  • 52 Week High

    $6.91

  • 52 Week Low

    $1.06

What are the historical returns of Repare Therapeutics (RPTX)?

  • 1 Month Returns

    -4.1%

  • 3 Months Returns

    -57.45%

  • 1 Year Returns

    -80.63%

  • 5 Years Returns

    -96.2%

Who is the Chief Executive Officer (CEO) of Repare Therapeutics ?

Mr. Lloyd Mitchell Segal is the current Chief Executive Officer (CEO) of Repare Therapeutics.